Results 121 to 130 of about 19,722 (182)

T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapy. [PDF]

Front Immunol
Hsu MT, Willimsky G, Hansmann L, Blankenstein T.   +3 more
europepmc   +1 more source

CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells. [PDF]

Cell Death Discov
Khamidullina AI, Yastrebova MA, Bruter AV, Nuzhina JV, Vorobyeva NE, Khrustaleva AM, Varlamova EA, Tyakht AV, Abramenko IE, Ivanova ES, Zamkova MA, Li J, Lim CU, Chen M, Broude EV, Roninson IB, Shtil AA, Tatarskiy VV.   +17 more
europepmc   +1 more source

Can PROTACs cure Leukemia? [PDF]

Leukemia
Sakamoto KM.
europepmc   +1 more source

Application of Omics Analyses in Pediatric B-Cell Acute Lymphoblastic Leukemia. [PDF]

Biomedicines
Vllahu M, Savarese M, Cantiello I, Munno C, Sarcina R, Stellato P, Leone O, Alfieri M.   +7 more
europepmc   +1 more source

Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia. [PDF]

Ann Hematol
Turkina A, Vinogradova O, Lomaia E, Shatokhina E, Shukhov O, Chelysheva E, Shikhbabaeva D, Nemchenko I, Petrova A, Bykova A, Siordiya N, Shuvaev V, Mikhailov I, Novikov F, Shulgina V, Hochhaus A, Ottmann O, Cortes J, Gale RP, Chilov G.   +19 more
europepmc   +1 more source

Chronic Myeloid Leukemia with a Rare Philadelphia Chromosome Variant Involving Chromosome 16. [PDF]

Am J Case Rep
Bahashwan SM.
europepmc   +1 more source

Current Advances in the Diagnosis and Treatment of Major Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Wang L, Li J, Arbitman L, Zhang H, Shao H, Martin M, Moscinski L, Song J.   +7 more
europepmc   +1 more source

KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3⁺ blast phase chronic myeloid leukemia. [PDF]

Mol Cancer
Kwon HJ, Shin JE, Khan A, Park SY, Kim J, Lee JY, Lee D, Lee S, Im CY, Moon H, Han YR, Tamai M, Akahane K, Inukai T, Lee W, Kim H, Kim HN, Ahn SM, Park HW, Kim DW.   +19 more
europepmc   +1 more source

BCR::ABL1-induced mitochondrial morphological alterations as a potential clinical biomarker in chronic myeloid leukemia. [PDF]

Cancer Sci
Suzuki K, Watanabe N, Torii S, Arakawa S, Ochi K, Tsuchiya S, Yamada K, Kawamura Y, Ota S, Komatsu N, Shimizu S, Ando M, Takaku T.   +12 more
europepmc   +1 more source